Histpat Eye Drop contains Olopatadine 0.1% w/v, an effective antihistamine and mast cell stabilizer indicated for the treatment of allergic conjunctivitis. Olopatadine acts by selectively inhibiting the release of histamine from mast cells and blocking H1 histamine receptors, thereby alleviating symptoms such as itching, redness, and swelling of the conjunctiva. This ophthalmic solution provides rapid relief from ocular allergy symptoms and helps prevent the late-phase allergic response. Histpat Eye Drop is suitable for patients experiencing seasonal or perennial allergic conjunctivitis and is typically administered as one drop in the affected eye(s) twice daily or as directed by a healthcare professional. The formulation is designed to ensure optimal ocular bioavailability while minimizing systemic absorption and adverse effects. Common side effects may include transient burning or stinging upon instillation, dry eyes, or headache, which are generally mild and self-limiting. Histpat Eye Drop should be used with caution in patients with hypersensitivity to Olopatadine or any other component of the formulation. It is contraindicated in viral, bacterial, or fungal eye infections. Proper administration and adherence to prescribed dosage enhance therapeutic outcomes and patient comfort in managing allergic ocular conditions.